Life Sciences

Life Sciences is a weekly peer-reviewed journal of experimental biology and medicine published by Elsevier under the Pergamon imprint, founded in 1962, with a 2025 Journal Impact Factor of 6.4《生命科学》（Life Sciences）是由（Elsevier）出版的生物学与医学实验研究周刊，创刊于 1962 年，2025 年影响因子为 6.4。

Scope

• It publishes high-quality research that advances understanding of the molecular, cellular, physiological and translational mechanisms underlying human health and disease该刊发表推进认识人类健康与疾病之分子、细胞、生理及转化机制的高质量研究。
• It seeks studies that provide mechanistic insight into biological processes relevant to disease pathogenesis, prevention, diagnosis or therapy该刊寻求对与疾病发病、预防、诊断或治疗相关的生物过程提供机制性认识的研究。
• Its scope spans molecular and cellular biology, physiology, pathophysiology, pharmacology, neuroscience, immunology, metabolism, biotechnology, and nutrition and health其范围涵盖分子与细胞生物学、生理学、病理生理学、药理学、神经科学、免疫学、代谢、生物技术及营养与健康。
• It particularly encourages submissions that bridge fundamental discovery and translational application该刊特别鼓励连接基础发现与转化应用的投稿。
• Welcomed themes include disease mechanisms, molecular diagnostics, biomarkers, therapeutic targets and intervention strategies欢迎的主题包括疾病机制、分子诊断、生物标志物、治疗靶点与干预策略。
• The journal publishes mechanistically driven research, and work lacking mechanistic advancement or focused solely on extracts of unknown composition is unlikely to be considered该刊发表机制驱动的研究，缺乏机制进展或仅聚焦成分不明提取物的稿件通常不予考虑。

History

• The journal was founded in 1962 by Pergamon Press in New York该刊于 1962 年由（Pergamon Press）在纽约创办。
• From 1970 to 1973 it split into two companion titles, Life Sciences Part 1, Physiology and Pharmacology and Life Sciences Part 2, Biochemistry, General and Molecular Biology1970 年至 1973 年间该刊分为两个分册，即（Life Sciences Part 1，Physiology and Pharmacology）与（Life Sciences Part 2，Biochemistry，General and Molecular Biology）。
• In 1973 the two parts were re-united into a single journal that continued the volume numbering from volume 13 in July 19731973 年两个分册合并为单一期刊，自 1973 年 7 月第 13 卷起延续卷号。
• It appeared semimonthly from 1973 to 1977 and is now published weekly该刊 1973 年至 1977 年间为半月刊，现为周刊。
• The journal has been published by Elsevier in Amsterdam since 2008该刊自 2008 年起由阿姆斯特丹的（Elsevier）出版。
• Its impact factor was 5.1 in 2024 and 6.4 in 2025, and it ranks in the first quartile of both the pharmacology and pharmacy and the medicine, research and experimental categories其影响因子 2024 年为 5.1，2025 年为 6.4，在药理学与药学及医学研究与实验两个类别均居第一分区。

Editors

• The editor-in-chief is Farah Sheikh of the University of California San Diego School of Medicine现任主编为加利福尼亚大学圣迭戈分校医学院的（Farah Sheikh）。
• The executive editors are Christopher T. Banek of the University of Minnesota Twin Cities and Yong Xu of China Pharmaceutical University执行编辑为明尼苏达大学双城分校的（Christopher T. Banek）与中国药科大学的（Yong Xu）。
• Associate editors include Marie Louise Bang in Milan, Brandon J. Biesiadecki at Ohio State and Yi Qu at the Shanghai University of Traditional Chinese Medicine副编辑包括米兰的（Marie Louise Bang）、俄亥俄州立大学的（Brandon J. Biesiadecki）与上海中医药大学的（Yi Qu）。
• The editorial board comprises 71 editors and board members from 16 countries and regions, including 38 in the United States and 14 in China编委会由来自 16 个国家与地区的 71 位编辑与编委组成，其中美国 38 位、中国 14 位。
• The editorial team is 75 percent men and 25 percent women编辑团队中男性占 75%，女性占 25%。
• Manuscripts are submitted through Editorial Manager, and the journal reports about 6 days from submission to first decision稿件经（Editorial Manager）系统投稿，该刊投稿至首次决定约 6 天。